Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armand Van Deun

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
External quality assessment of sputum smear microscopy: a matter of careful technique and organisationArmand Van Deun
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
How Second-Line Injectable Drugs WorkArmand Van Deun, Tom Decroo
The Lancet. Infectious Diseases|January 29, 2022
Implications of bedaquiline-resistant tuberculosisTom Decroo, Armand van Deun
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|June 7, 2021
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?Armand Van Deun, Tom Decroo
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosisHans L Rieder, Armand Van Deun
Public Health Action|September 23, 2015
DOT, S, or DOTS?Armand Van Deun, Hans L Rieder
The European Respiratory Journal|June 3, 2017
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistanceArmand Van Deun, Chen-Yuan Chiang
The Journal of Antimicrobial Chemotherapy|January 3, 2018
Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre studyTom Decroo, Armand Van Deun, Lutgarde Lynen
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 11, 2006
Moving forward with evidence and controversies: the challenges of MDR-TBChen-Yuan Chiang, Armand Van Deun, Jose A Caminero
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Will the bleach method keep its promise in sputum smear microscopy?Armand Van Deun, Sang Jae Kim, Hans L Rieder
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 12, 2003
External quality assessment of sputum smear microscopy: a matter of careful technique and organisationArmand Van Deun
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2020
How Second-Line Injectable Drugs WorkArmand Van Deun, Tom Decroo
The Lancet. Infectious Diseases|January 29, 2022
Implications of bedaquiline-resistant tuberculosisTom Decroo, Armand van Deun
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|June 7, 2021
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?Armand Van Deun, Tom Decroo
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosisHans L Rieder, Armand Van Deun
Public Health Action|September 23, 2015
DOT, S, or DOTS?Armand Van Deun, Hans L Rieder
The European Respiratory Journal|June 3, 2017
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistanceArmand Van Deun, Chen-Yuan Chiang
The Journal of Antimicrobial Chemotherapy|January 3, 2018
Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre studyTom Decroo, Armand Van Deun, Lutgarde Lynen
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 11, 2006
Moving forward with evidence and controversies: the challenges of MDR-TBChen-Yuan Chiang, Armand Van Deun, Jose A Caminero
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Will the bleach method keep its promise in sputum smear microscopy?Armand Van Deun, Sang Jae Kim, Hans L Rieder
Pageof 8